Our findings indicate that aldh5a1-/- NSCs express most of the markers of the SSADHD mouse brain and hold significant value in the screening of potential therapeutics applicable to human SSADHD. Here, ALDH5A1 is linked to succinic semialdehyde dehydrogenase deficiency.